Atlassian Corporation PLC vs Vital Farms Inc — how do they compare? Atlassian Corporation PLC trades at $204 (market cap $49.56B), while Vital Farms Inc trades at $9.45 (market cap $396.69M). The key difference: Atlassian Corporation PLC is far larger — about 124.9× Vital Farms Inc's market cap, and Atlassian Corporation PLC is trading nearer its 52-week high, Vital Farms Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Atlassian Corporation PLC for 64 Days and Vital Farms Inc for 14 Days on average.
| TEAM | VITL | |
|---|---|---|
Market Cap | $49.56B | $396.69M |
Volume | 1,747,462 | 1,219,207 |
Sector | Technology | Consumer Staples |
52-Week High | $203.57 | $43.68 |
52-Week Low | $57.15 | $8.28 |
Typical Hold Time | 64 Days | 14 Days |
Enterprise Value | $49.56B | $483.70M |
Signals from Pluang's Aura AI — not financial advice
Atlassian (TEAM) trades at $203.57, up 4.94% with strong technical momentum and bullish moving averages. The stock shows improving fundamentals with revenue growth from $5.22B in 2025 to projected $6.6B in 2026, though it remains unprofitable with a -0.82% net margin. Recent earnings beats and accelerating cloud/AI adoption drive positive sentiment, with analyst consensus strongly bullish at 70% buy ratings.
Outlook remains positive due to cloud migration progress and AI product adoption, but investors face valuation concerns with elevated P/S of 7.75 and EV/EBITDA of 233.57. Key risks include persistent profitability challenges and competitive pressures in enterprise software. Current price exceeds consensus target of $191.16, suggesting near-term consolidation potential.
Vital Farms (VITL) trades at $9.24, down 1.7% on the day, amid a bearish technical signal and challenging fundamentals. Recent earnings show volatility with a Q2 2026 loss of $0.47 per share, though it slightly beat expectations, while revenue declined 10% year-over-year in that quarter. The company faces pressure from egg pricing and oversupply, as noted in recent news, but maintains a 'Buy' consensus from analysts with a $13.11 price target.
The outlook is mixed: strong analyst support and potential strategic options like a sale offer upside, but weak profitability margins and cash flow concerns pose significant risks. Investors should weigh the company's market position against ongoing industry headwinds and execution challenges in the near term.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →